Comparative study of PSMA expression in the prostate of mouse, dog, monkey, and human

Prostate

Volumn 66, Issue 9, 2006, Pages 903-910

  Aggarwal, Saurabh ^a   Ricklis, Rebecca M ^b   Williams, Simon A ^b   Denmeade, Samuel R ^a,c  

^a Johns Hopkins University   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Bunting Blaustein Cancer Research Building ^*  (United States)

Author keywords

Dog; Monkey; Primate; PSMA; Toxicology

Indexed keywords

MESSENGER RNA; PRODRUG; PROSTATE SPECIFIC MEMBRANE ANTIGEN; PROTOXIN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; HOMOGENATE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYDROLYSIS; MACACA; MONKEY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, SURFACE; BLOTTING, WESTERN; DISEASE MODELS, ANIMAL; DOGS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLUTAMATE CARBOXYPEPTIDASE II; HUMANS; IMMUNOHISTOCHEMISTRY; MACACA MULATTA; MALE; MICE; PROSTATE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOXICITY TESTS;

EID: 33744938153     PISSN: 02704137     EISSN: 10970045     Source Type: Journal    
DOI: 10.1002/pros.20413     Document Type: Article

References (26)

1. Denmeade SR, Jakobsen CM, Janssen S, Khan SR, Garrett ES, Lilja H, Christensen SB, Isaacs JT. Prostate-specific antigen-activated thapsigargin prodrug as targeted therapy for prostate cancer. J Natl Cancer Inst 2003;95:990-1000.
2. Janssen S, Jakobsen CM, Rosen DM, Ricklis KM, Reineke U, Christensen SB, Lilja H, Denmeade SR. Screening a combinatorial peptide library to develop a human glandular kallikrein 2-activated prodrug as targeted therapy for prostate cancer. Mol Cancer Ther 2004;3:1439-1450.
3. Mhaka A, Gady AM, Rosen DM, Lo KM, Gillies SD, Denmeade SR. Use of methotrexate-based peptide substrates to characterize the substrate specificity of prostate-specific membrane antigen (PSMA). Cancer Biol Ther 2004;3:551-558.
4. Rosen M, Gady AM, Buckley T, Donmeade SR. Enzymatic activation of a modified proaerolysin toxin by prostate-specific antigen (PSA) as treatment for prostate cancer. Proc Am Assoc Cancer Res 2002;43:92.
5. Yousef GM, Diamandis EP. An overview of the kallikrein gene families in humans and other species: Emerging candidate tumour markers. Clin Biochem 2003;36:443-452.
6. Olsson AY, Valtonen-Andre C, Lilja H, Lundwall A. The evolution of the glandular kallikrein locus: Identification of orthologs and pseudogenes in the cotton-top tamarin. Gene 2004;343:347-355.
7. Bacich DJ, Pinto JT, Tong WP, Heston WD. Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/ NAALADase/folate hydrolase. Mamm Genome 2001;12(2):117-123.
8. Slusher BS, Robinson MB, Tsai G, Simmons RL, Richards SS, Coyle JT. Rat brain N-acetylated alpha-linked acidic dipeptidase activity. J Biol Chem 1990;265:21297-21301.
9. Luthi-Carter R, Berger UV, Barczak AK, Enna M, Coyle JT. Isolation and expression of a rat brain cDNA encoding glutamate carboxypeptidase II. Proc Natl Acad Sci USA 1998;95:3215-3220.
10. Halsted CH, Ling EH, Luthi-Carter R, Villanueva JA, Gardner JM, Coyle JT. Folylpoly-gamma-glutamate carboxypeptidase from pig jejunum. Molecular characterization and relation to glutamate carboxypeptidase II. J Biol Chem 1998;273:20417-20424.
11. Yang D, Holt GE, Velders MP, Kwon ED, Kast WM. Murine six-transmembrane epithelial antigen of the prostate, prostate stem cell antigen, and prostate-specific membrane antigen: Prostate-specific cell-surface antigens highly expressed in prostate cancer of transgenic adenocarcinoma mouse prostate mice. Cancer Res 2001;615857-5860.
12. Schmittgen TD, Zakrajsek BA, Hill RE, Liu Q, Reeves JJ, Axford PD, Singer MJ, Reed MW. Expression pattern of mouse homolog of prostate-specific membrane antigen (FOLH1) in the transgenic adenocarcinoma of the mouse prostate model. Prostate 2003;55:308-316.
13. Huang X, Bennett M, Thorpe PE. Anti-tumor effects and lack of side effects in mice of an immunotoxin directed against human and mouse prostate-specific membrane antigen. Prostate 2004;61:1-11.
14. Carter RF, Feldman AR, Coyle JT. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacological characteristics of a neuropeptidase. Proc Natl Acad Sci USA 1996;93:749-753.
15. Robinson MB, Blakely RD, Coulo K, Coyle JT. Hydrolysis of the brain dipeptide N-acetyl-asparlyl-L-glutamate. J Biol Chem 1987;262:14498-14506.
16. Pinto JT, Suffoleto BP, Berzin TM, Qiao CH, Lin S, Tong W, May F, Mukherjee B, Fleston WD. Prostate-specific membrane antigen: A novel folate hydrolase in human prostatic carcinoma cells. Clin Cancer Res 1996;2:1445-1451.
17. Tiffany CW, Lapidus RC, Merion A, Calvin DC, Slusher BS. Characterization of the enzymatic activity of PSM: Comparison with brain NAALADase. Prostate 1999;39:28-35.
18. Barnes A, Bee A, Bell S, Gilmore W, Mee A, Morris R, Carter SD. Immunological and inflammatory characterisation of three canine cell lines: K1, K6 and DH82. Vet Immunol Immunopathol 2000;75:9-25.
19. Gao J, Arnold JT, Isaacs JT. Conversion from a paracrine to an autocrine mechanism of androgen-stimulated growth during malignant transformation of prostatic epithelial cells. Cancer Res 2001;61:5038-5044.
20. Shulke N, Varlamova OA, Donovan GP, Ma D, Gardner JP, Morrissey DM, Arrigale RR, Zhan C, Chodera AJ, Surowitz KG, Madden PJ, Heston WDW, Olson WC. The homodimer of prostate-specific membrane antigen is a functional target for cancer therapy. Proc Natl Acad Sci 2003;100:12590-12595.
21. Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci USA 2005;102:5981-5986.
22. Anilkumar G, Rajasekaran SA, Wang S, Hankinson O, Bander NH, Rajasekaran AK. Prostate-specific membrane antigen association with filamin A modulates its internalization and NAALADase activity. Cancer Res 2003;63:2645-2648.
23. Rajasekaran AK, Anilkumar G, Christiansen JJ. Is prostate-specific membrane antigen a multifunctional protein? Am J Physiol Cell Physiol 2005;288:C975-C981.
24. Wright GL Jr, Grob BM, Haley C, Grossman K, Newhall K, Petrylak D, Troyer J, Konchuba A, Schellhammer PF, Moriarity R. Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology 1996;48:326-334.
25. Watt F, Martorana A, Brookes DE, Ho T, Kingsley E, O'Keefe DS, Russell PJ, Heston WD, Molloy PL. A tissue-specific enhancer of the prostate-specific membrane antigen gene, FOLH1. Genomics 2001;73:243-254.
26. Bacich DJ, Harsch KM, Heston WDW. Transgenic mice expressing human prostate-specific membrane antigen (PSMA) in their prostate: A potential model for prostate cancer initiation, development and therapy. Proc Am Assoc Cancer Res 2002;43:312-313.